The intraoperative detection of ovarian adenocarcinoma using radiolabeled CC49 monoclonal antibody and a hand-held gamma-detecting probe

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 4, 1997, Pages 287-294

  McIntosh, David G ^a   Colcher, David ^a   Seemayer, Thomas ^a   Smith, McClure L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; MONOCLONAL ANTIBODY I 125;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; OVARY ADENOCARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCINTISCANNING;

EID: 0031445789     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.287     Document Type: Article

References (15)

1. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin compared with Paclitaxel and Cisplatin in patients with Stage III and Stage IV ovarian cancer. New England Journal 1996; 334:1.
2. Berek J, Hacker N, Lagasse L, Poth T, Resnick B, Nieberg R. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status. Obstetrics & Gynecology 1984;64(2):207.
3. Miller DS, Spirtos NM, Ballon SC, Cox RS, Soriero OM, Teng NNH. Exploratory laparotomy for epithelial ovarian carcinoma, minimal diagnostic and therapeutic value in patients with persistent cancer Cancer 1992; 69:502.
4. Podczaski E, Manetta A, Kaminski P, Ricelli A, Larson J, DeGeest K, Mortel R. Survival of patients with ovarian epithelial carcinomas after second-look laparotomy Gynecologic Oncology 1990;36:43.
5. Arnold MW, Schneebaum S, Berens A, et al. Intraoperative detection of colorectal cancer with radioimmunoguided surgery (RIGS) and CC49, a second-generation monoclonal antibody. Annals of Surgery 1992;216:627.
6. Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. Journal of the National Cancer Institute 1986;76:995.
7. Fraker PJ, and Speck JC. Protein and cell membrane iodinations with a sparingly soluable chloramide 1,3,4,6 tetrachloro-3α, 6α diphenyl-glycouril. Biochem Biophys Res Commun 1978;80:849-857.
8. Gero EJ, Colcher D, Ferroni P, Melsheimer R, Giani S, Schlom J, Kaplan P. CA 72-4 Radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients. Journal of Clinical Laboratory Analysis 1989,3:360.
9. 111In-CYT-103 immunoscintigraphy in ovarian cancer. Gynecologic Oncology 1993;48:285.
10. Divgi CR. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer. Oncology 1996; 10(6):939.
11. 1 Radiology 175 1990;1:163.
12. Carrasquillo JA, Sugarbaker P, Colcher D, et al. Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody The Journal of Nuclear Medicine 1988;29:1022.
13. Harrison KA and Tempero M. Diagnostic use of radiolabeled antibodies for cancer. Oncology 1995; 9(7):625.
14. Reinsberg J and Gast B Human antiidiotypic antibodies against OC 125 strongly interfere with one-step assays of CA 125 employing OC 125 and M 11 antibodies. Clinical Chem 1994;40(6):951.
15. Rubin SC and Sutton GP. Ovarian Cancer, McGraw-Hill, Inc, 1993, New York, NY, p. 274.